Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet-activating factor antagonists decrease the inflammatory nociceptive response in rats.

Lisa A Teather1, Jane E Magnusson, Richard J Wurtman

  • 1Massachusetts Institute of Technology, Department of Brain and Cognitive Sciences, 45 Carleton Street, E25-604, Cambridge, MA 02139, USA. lteather@mit.edu

Psychopharmacology
|October 10, 2002
PubMed
Summary

Platelet-activating factor (PAF) plays a role in persistent pain. Blocking both cell surface and intracellular PAF binding sites reduced pain responses in a rat model, suggesting potential therapeutic targets for pain management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of the Diet on Brain Neurotransmitters.

Nutrition reviews·2019
Same author

Fenfluramine: Back From the Dead.

Clinical therapeutics·2018
Same author

Synapse formation in the brain can be enhanced by co-administering three specific nutrients.

European journal of pharmacology·2017
Same author

Connectomics and other novel methods for examining neural systems.

Metabolism: clinical and experimental·2017
Same author

Depression can beget obesity can beget depression.

The Journal of clinical psychiatry·2015
Same author

How Anticholinergic Drugs Might Promote Alzheimer's Disease: More Amyloid-β and Less Phosphatidylcholine.

Journal of Alzheimer's disease : JAD·2015

Area of Science:

  • Neuroscience
  • Pharmacology
  • Pain Research

Background:

  • Platelet-activating factor (PAF) is a mediator involved in cellular responses, including inflammation.
  • PAF acts through both cell surface and intracellular binding sites.
  • Inflammatory stimuli can increase PAF synthesis and release.

Purpose of the Study:

  • To investigate the role of PAF in inflammatory nociception using the formalin test in rats.
  • To determine the specific sites of PAF action in nociceptive transmission.
  • To evaluate the efficacy of selective PAF antagonists on pain responses.

Main Methods:

  • Male Sprague-Dawley rats were administered systemic injections of PAF antagonists BN 52021 (cell surface) or BN 50730 (intracellular), or vehicle.
  • Antagonists were given 40 minutes before formalin injection into the hindpaw.

Related Experiment Videos

  • Nociceptive behavioral responses were measured during the early and late phases of the formalin test.

    • Main Results:

    • Both BN 52021 and BN 50730 significantly reduced nociceptive responses.
    • This reduction was observed specifically in the late phase of the formalin test, not the early phase.
    • The findings indicate involvement of both extracellular and intracellular PAF binding sites.

    Conclusions:

    • Endogenous PAF contributes to nociceptive transmission, particularly in persistent pain states.
    • Both intracellular and cell surface PAF binding sites are implicated in pain modulation in rats.
    • PAF antagonists show potential for treating acute and chronic pain conditions.